This hypothesis would explain the paucity of POU2F3-positive breast cancers compared with the more frequent luminal-type and HER2-positive/HR-negative breast cancers that are derived from the much more abundant POU2F3-negative epithelial cells. The gene discussed is ERBB2; the disease is breast carcinoma.